arsenic trioxide has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chau, D; Kwong, YL; Piao, W; Tse, E; Yue, LM | 1 |
1 other study(ies) available for arsenic trioxide and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma.
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Humans; Lymphoma, Large-Cell, Anaplastic; Oxides; Protein-Tyrosine Kinases | 2017 |